{"transactions":[{"id":2360817,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":129737,"kind":"person","name":"McCabe John P.","position":1,"cik":"0001630720","reported_name":"McCabe John P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-02T16:40:29.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":90000,"derivative":{"exercise_price":2,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-014780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671818/000120919122014780/doc4.xml","form_type":"4"}},{"id":2813733,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":129737,"kind":"person","name":"McCabe John P.","position":1,"cik":"0001630720","reported_name":"McCabe John P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-03T18:14:42.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":76894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":76894,"derivative":{"exercise_price":15.85,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":76894},"source":{"system":"sec-edgar","filing":"0001209191-21-017203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671818/000120919121017203/doc4.xml","form_type":"4"}},{"id":3890274,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":129737,"kind":"person","name":"McCabe John P.","position":1,"cik":"0001630720","reported_name":"McCabe John P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-18T20:14:33.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":179848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 48 successive equal monthly installments measured from June 14, 2018."}],"balance_after":179848,"derivative":{"exercise_price":1.35,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":179848},"source":{"system":"sec-edgar","filing":"0001615219-18-000038","document":"wf-form4_152935285457366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521918000038/wf-form4_152935285457366.xml","form_type":"4"}},{"id":4094303,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":129737,"kind":"person","name":"McCabe John P.","position":1,"cik":"0001630720","reported_name":"McCabe John P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-19T15:00:18.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018."}],"balance_after":100000,"derivative":{"exercise_price":3.98,"expiration_date":"2028-01-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001615219-18-000005","document":"wf-form4_151637400432045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521918000005/wf-form4_151637400432045.xml","form_type":"4"}},{"id":4484971,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":129737,"kind":"person","name":"McCabe John P.","position":1,"cik":"0001630720","reported_name":"McCabe John P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-20T14:03:31.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 48 successive equal monthly installments measured from January 18, 2017."}],"balance_after":67000,"derivative":{"exercise_price":4.58,"expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001615219-17-000009","document":"wf-form4_148492099847637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521917000009/wf-form4_148492099847637.xml","form_type":"4"}},{"id":4565138,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":129737,"kind":"person","name":"McCabe John P.","position":1,"cik":"0001630720","reported_name":"McCabe John P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Treasurer"}}],"security":"Common Stock","published_at":"2016-11-07T21:40:39.000Z","date":"2016-11-07","kind":"purchase","acquired":true,"shares":1650,"price":6.01,"value":9916.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $5.99 to $6.01. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range."}],"balance_after":1650,"source":{"system":"sec-edgar","filing":"0001615219-16-000228","document":"wf-form4_147855482137744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521916000228/wf-form4_147855482137744.xml","form_type":"4"}}]}